Diagnostic Imaging Support AI "EIRL" Series Obtains Regulatory Approval in Six Southeast Asian Countries
LPIXEL, a life science AI startup, has obtained regulatory approval for its diagnostic imaging support AI "EIRL" series in six Southeast Asian countries. This is expected to accelerate the company's global expansion and contribute to the spread of medical AI in Asia.
📋 Article Processing Timeline
- 📰 Published: April 16, 2026 at 14:06
- 🔍 Collected: April 16, 2026 at 14:31 (25 min after Published)
- 🤖 AI Analyzed: April 19, 2026 at 00:50 (58h 18m after Collected)
LPIXEL is a startup with strengths in AI image analysis technology in the life science domain. We develop medical imaging diagnosis support AI and an image analysis AI for academia and drug discovery called "IMACEL."